ArticleJournal of applied clinical medical physics2026
Development of a virtual phantom for HDR cervical cancer brachytherapy: A multi-institutional tool for training, quality assurance, and variability reduction.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundHigh-dose-rate brachytherapy (HDR-BT) is a critical modality in the treatment of cervical cancer, requiring accurate and efficient treatment planning. Unlike external beam radiation therapy, HDR-BT demands specialized skills and training. However, accessible and standardized educational tools-particularly virtual phantoms-remain limited. PURPOSE: This study aimed to develop a virtual phantom tailored for HDR-BT treatment planning in cervical cancer management. The objective was to support planner training, reduce interobserver error, and provide a scalable platform for quality assurance and educational use.
methodsFour virtual phantoms (VP1-VP4) were generated using computed tomography images of physical models equipped with different applicators (Fletcher, Geneva, VCMC, and Venezia). Dose constraints were initially established through a single-institutional planning study (SIPS) and validated via a multi-institutional planning study involving seven institutions. Dose-volume parameters (DVPs) were analyzed to assess compliance with the constraints and to quantify inter-planner error (IPE) and inter-institutional error (IIE). The coefficient of variation (CV) and F-tests were employed to evaluate variability.
resultsInitial compliance with SIPS-defined dose constraints ranged from 35.4% to 70.8%. As compliance was low across all phantoms, we adjusted the spatial relationships between the target volume and organs at risk. The compliance then improved to 83.3%-100.0%. IIE was greater than IPE, with several DVPs exhibiting CVs above 20%. The hyper-dose sleeve (V200%) demonstrated the highest variability, with CVs exceeding 40% in some cases. These findings emphasize the importance of standardized training tools for reducing interobserver variability.
conclusionsThe developed virtual phantoms offer practical and accessible tools for HDR-BT treatment planning education. Its digital format enables broad dissemination and adaptability across institutions, supporting both training and clinical use. Ongoing refinement will be necessary to ensure continued relevance in evolving clinical environments and contribution to consistent, high-quality care in gynecologic brachytherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.